LOS ANGELES--(BUSINESS WIRE)--Cougar Biotechnology, Inc. (Nasdaq: CGRB - News), a biotechnology company engaged in the in-license and development of clinical stage cancer drug candidates, today reported results for the fourth quarter and year ended December 31, 2007.
